Price target
5.200.000.00%
The 5 analysts offering 1 year price forecasts for 0SGC have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 0SGC in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0SGC EPS for the last quarter is −0.10 USD despite the estimation of −0.09 USD. In the next quarter EPS is expected to reach −0.08 USD. Track more of ARBUTUS BIOPHARMA CORP NPV financials and stay on top of what is up with the company.
In the next quarter ARBUTUS BIOPHARMA CORP NPV revenue is expected to reach 1.59 M USD. Check out ARBUTUS BIOPHARMA CORP NPV revenue and earnings and make informed decisions.
According to analysts, 0SGC price target is 5.20 USD with a max estimate of 7.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch ARBUTUS BIOPHARMA CORP NPV stock price chart and keep track of the current situation with 0SGC news and stock market news.
We've gathered opinions of 5 analysts rating 0SGC stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.